about
Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunamiAPOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.Longitudinal brain structural changes in preclinical Alzheimer's disease.Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia.Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease.Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease.Cortical microstructural changes along the Alzheimer's disease continuum.Visual hallucinations in patients with acute stroke: a prospective exploratory study.Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease.The pitfalls of biomarker-based classification schemes.Effect of REST on brain metabolism in the Alzheimer disease continuum.Altered topology of the functional speech production network in non-fluent/agrammatic variant of PPADOWN ALZHEIMER BARCELONA NEUROIMAGING INITIATIVE (DABNI): A PROSPECTIVE LONGITUDINAL BIOMARKER COHORT TO STUDY ALZHEIMER’S DISEASE IN DOWN SYNDROMEOBESITY IS ASSOCIATED WITH INCREASED CSF PHOSPHO-TAU LEVELS AND COGNITIVE DECLINE IN HEALTHY ELDERLYCSF β-AMYLOID AND PHOSHO-TAU INTERACTIONS ON BRAIN STRUCTURE IN PRECLINICAL ADCSF β-AMYLOID AND PHOSHO-TAU INTERACTIONS ON BRAIN STRUCTURE IN PRECLINICAL ADRELATIONSHIP BETWEEN CSF YKL-40 AND CORTICAL THICKNESSInflammation markers in CSF and MRI spectroscopy in Alzheimer's disease pre-dementia stagesAPP-derived peptides reflect neurodegeneration in frontotemporal dementiaCortical microstructural correlates of astrocytosis in autosomal dominant Alzheimer diseaseAgreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
P50
Q35572825-76E1B138-A7BC-4CB7-B4E7-C539D15B368BQ36413581-407522DE-6E34-4A51-873B-FADA4051859BQ38375870-5418EEE4-08D6-4029-925C-CAD1FA31FB38Q39036392-4571CAAA-DD90-4E2A-A952-FFADD53C6DD2Q39332197-3FC7ED4A-E5C1-4F78-9227-ECFD4E2D8AE6Q40196222-9F444164-EF95-42EC-8E46-E5C0FF681087Q41635651-CA737166-F3EC-409B-BB33-85E938A350DDQ43593305-9D9D0692-670D-4CA5-BFD7-DD1D9678CA6DQ47134219-3A1EF56E-CD31-4837-8E73-29AF81EFBAFEQ47231424-47541AA6-9EAF-430B-A459-DBF7A0531991Q47751416-C4DBB90F-FFF1-49CC-AAAC-449DB0857D47Q48234063-BE7D7064-0464-4E0D-A9E3-05E0E52E2393Q50202743-10F88C34-0939-4730-8BEF-A510715DABF7Q50440328-CC9603A3-CFF2-49C6-9652-D4A3F00B9161Q57134138-8180F9A9-B3E1-4A98-9F38-D52005228649Q61730438-7D127CB7-B674-4260-836C-EB412B68F5E8Q61730440-9A2B83A1-6BD5-47D2-B93D-782CCE7BE948Q61730443-AF7A3E6D-3FAD-4418-B99E-91E61400E5CFQ61730444-FB6DFB1C-74EF-44AD-9D7F-875ADFA56E0BQ61730447-0CD28846-5D9E-4B07-B464-09EE75312546Q61730448-BAE42A92-4DEC-4D44-86CC-9A30A220416CQ91596795-135B36AC-5C1F-4CC9-8915-7B6ACE81F357Q91932964-5DCEDD14-559F-49AF-9496-822A2FE9E67BQ92974015-B7E73869-D022-4B51-AFDA-464D5C7080FE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eduard Vilaplana
@ast
Eduard Vilaplana
@en
Eduard Vilaplana
@es
Eduard Vilaplana
@nl
type
label
Eduard Vilaplana
@ast
Eduard Vilaplana
@en
Eduard Vilaplana
@es
Eduard Vilaplana
@nl
prefLabel
Eduard Vilaplana
@ast
Eduard Vilaplana
@en
Eduard Vilaplana
@es
Eduard Vilaplana
@nl
P106
P1153
56197641600
P31
P496
0000-0002-1809-8435